Thomas Plavac, MD
Cardiovascular Disease · Meridian, MSNPI 1649272782
Payments from drug & device makers
Across 374 payments — averaging $25.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1K
- Medtronic$1K
- Penumbra, Inc.$1K
- Abiomed$922
- Johnson & Johnson$724
- AstraZeneca$528
- plus $3K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 101 | $1,458 |
| Medtronic(2 entities) | 53 | $1,457 |
| Penumbra, Inc. | 6 | $1,154 |
| Abiomed | 19 | $922 |
| Johnson & Johnson | 35 | $724 |
| AstraZeneca | 14 | $528 |
| E.r. Squibb & Sons, L.L.C. | 28 | $523 |
| Merck | 23 | $496 |
| Amgen | 18 | $397 |
| Pfizer | 18 | $323 |
| Inari Medical, Inc. | 2 | $309 |
| Lexicon Pharmaceuticals, Inc. | 4 | $169 |
| Astellas Pharma US Inc | 6 | $130 |
| Esperion Therapeutics, Inc. | 6 | $121 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $79 |
| Sanofi-aventis U.S. LLC | 5 | $76 |
| Kowa Pharmaceuticals America, Inc. | 4 | $60 |
| Regeneron Healthcare Solutions, Inc. | 3 | $53 |
| Lilly USA, LLC | 2 | $43 |
| Cvrx, Inc. | 2 | $41 |
| Amarin Pharma, Inc. | 2 | $38 |
| Abbott | 2 | $37 |
| Bayer | 2 | $35 |
| W. L. Gore & Associates, Inc. | 1 | $31 |
| Boehringer Ingelheim | 2 | $30 |
| Inspire Medical Systems, Inc. | 1 | $29 |
| Silk Road Medical, Inc. | 1 | $28 |
| Boston Scientific | 1 | $22 |
| United Therapeutics Corporation | 1 | $22 |
| Cardiva Medical, Inc. | 1 | $21 |
| Scpharmaceuticals Inc. | 1 | $18 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $17 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
| Novo Nordisk | 1 | $12 |
How this compares
$9,419 in reported general payments places this provider in the 65th percentile of 144 cardiovascular disease providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Meridian
- Larry HaileyMeridian$10K
- Charles DavenportMeridian$9K
- Randall JoransenMeridian$7K
- Barry BertoletTupelo$6.4M
- Dharmesh PatelSouthaven$1.9M
- James HaysJackson$782K
- John EstessTupelo$416K
- Donny StokesJackson$277K
- Mahmoud ZayedPascagoula$103K
- Benjamin BlossomTupelo$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.